Poster
Framework for Real-World Data Used in Regulatory Submissions
Characteristics of Patients Initiating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (RAs) for Cardiometabolic Risk Reduction in a Medicare Population
Similar Proportions and Temporal Patterns of Influenza, RSV, and hMPV among ESKD patients tested between 2020 and 2023
A Need for Infection Prevention Among Patients With ESKD on Maintenance Dialysis: A First Step in Understanding How SARS-CoV-2 Impacts This Population
Prior SARS-CoV-2 in patients with CAR-T negatively impacts overall survival, highlighting the need for targeted prophylaxis strategies
Characteristics of Patients Initiating Wegovy for Cardiovascular Risk Reduction in a Medicare Population
Podium Presentation
Characteristics of RWE used in regulatory decision-making for marketing authorization applications
Review of Real-World Evidence (RWE) in Marketing Authorization Applications Highlight Differences in Evidentiary Standards Among Regulatory and Health Technology Assessment (HTA) Bodies
Publication
Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records
Copyright ©2026 Landmark Science, Inc. All Rights Reserved
